HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $12
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Ocular Therapeutix (NASDAQ:OCUL) and raises the price target from $10 to $12.
June 13, 2023 | 10:13 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Ocular Therapeutix and raises the price target from $10 to $12.
The news of HC Wainwright & Co. maintaining a Buy rating and raising the price target for Ocular Therapeutix (NASDAQ:OCUL) from $10 to $12 is positive for the stock. This indicates that the analyst has confidence in the company's performance and growth potential, which could lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100